600161 天坛生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额468,8222,393,5761,126,002980,350702,110
投资活动产生之现金流量净额(783,214)(1,246,907)(1,870,901)(2,184,964)(620,468)
筹资活动产生之现金流量净额(2,015)(508,084)(378,202)2,774,371254,166
汇率变动对现金及现金等价物的影响1-0(48)(11)(218)
现金及现金等价物净增加/(减少)(316,405)638,585(1,123,149)1,569,747335,590
期初现金及现金等价物余额2,832,5872,194,0023,317,1511,747,4051,411,815
期末现金及现金等价物余额2,516,1822,832,5872,194,0023,317,1511,747,405